Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-25 @ 2:27 AM
NCT ID:
NCT00292734
Eligibility Criteria:
Inclusion Criteria:
* Depressive and dysthimic patients in acute phase of mild to moderate severity
* Depressive and dysthimic patients suffering from secondary insomnia (DSM IV) recent antidepressant therapy (less than 1 week)
Exclusion Criteria:
* Regularly use of sleeping pills in the last 2-3 month
* Use of any sleeping pils in the last week
* Insufficient hepatic
* Myasthenia gravis
* Proven hypersensivity to Zolpidem
* Evidence of clinically relevant nervous system disorders (other neurologic/psychiatric diseases associated with depression)
* History of evidence of alcohol or drug abuse
* Evidence of clinically relevant cardiovascular, haematologic, hepatic, gastrointestinal, renal, pulmonary or endocrinologic diseases
* Abnormal snore
* Work an alternating shift
* Suffering from periodic leg movement disorder and sleep apnea
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00292734
Study Brief:
Protocol Section:
NCT00292734